EDGAR Filing Documents for 0001654954-18-011104

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001654954-18-011104

Filing Date

2018-10-15

Accepted

2018-10-15 06:13:20

Documents

Period of Report

2018-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	QUARTERLY REPORT	mbvx_10q.htm	10-Q	848013
2	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	mbvx_ex311jun30.htm	EX-31.1	13031
3	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	mbvx_ex312jun30.htm	EX-31.2	12944
4	CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE	mbvx_ex32jun30.htm	EX-32	11026
	Complete submission text file	0001654954-18-011104.txt		3004553

Data Files

Seq	Description	Document	Type	Size
5	XBRL INSTANCE DOCUMENT	mbvx-20180630.xml	EX-101.INS	386289
6	XBRL TAXONOMY EXTENSION SCHEMA	mbvx-20180630.xsd	EX-101.SCH	32680
7	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	mbvx-20180630_cal.xml	EX-101.CAL	45259
8	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	mbvx-20180630_def.xml	EX-101.DEF	97077
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE	mbvx-20180630_lab.xml	EX-101.LAB	224064
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	mbvx-20180630_pre.xml	EX-101.PRE	190195

Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121

Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405

MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)